Michael G. Rinaldi

Active 1974–2010

130
Papers
26,209
Citations
97
h-index
130
i10-index

Citations

Citations per year for Michael G. Rinaldi1974: 1 citations1986: 1 citations1987: 2 citations1988: 9 citations1989: 27 citations1990: 23 citations1991: 20 citations1992: 37 citations1993: 53 citations1994: 79 citations1995: 98 citations1996: 109 citations1997: 149 citations1998: 182 citations1999: 233 citations2000: 189 citations2001: 237 citations2002: 335 citations2003: 321 citations2004: 249 citations2005: 258 citations2006: 265 citations2007: 318 citations2008: 232 citations2009: 235 citations2010: 211 citations2011: 209 citations2012: 139 citations2013: 119 citations2014: 171 citations2015: 119 citations2016: 107 citations2017: 89 citations2018: 87 citations2019: 333 citations2020: 267 citations2021: 280 citations2022: 186 citations2023: 115 citations2024: 219 citations2025: 75 citations1975–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,886 citing papers, 27.7% of this breakdownUnited Kingdom: 335 citing papers, 4.9% of this breakdownFrance: 278 citing papers, 4.1% of this breakdownNetherlands: 277 citing papers, 4.1% of this breakdownSpain: 272 citing papers, 4% of this breakdownChina: 258 citing papers, 3.8% of this breakdownGermany: 258 citing papers, 3.8% of this breakdownBrazil: 238 citing papers, 3.5% of this breakdownIndia: 221 citing papers, 3.2% of this breakdownItaly: 216 citing papers, 3.2% of this breakdownCanada: 168 citing papers, 2.5% of this breakdownAustralia: 167 citing papers, 2.5% of this breakdown
0%27.7%Other 32.7%

Fields

  • Medicine75.2%
  • Biochemistry, Genetics and Molecular Biology12.8%
  • Agricultural and Biological Sciences3.9%
  • Immunology and Microbiology1.7%
  • Environmental Science1.4%
  • Veterinary1%
  • Other4%

Topics

  • Antifungal resistance and susceptibility22.6%
  • Fungal Infections and Studies15.1%
  • Plant Pathogens and Fungal Diseases6.4%
  • Nail Diseases and Treatments4.1%
  • Infectious Diseases and Mycology3.2%
  • Pneumocystis jirovecii pneumonia detection and treatment2.6%
  • Other46%

Coauthors

All papers

Open in search
  1. Infections Caused byScedosporiumspp

    Authors: , , , , , , , , , , , , , , - Clinical Microbiology Reviews 2008 cited by 757

  2. Internet-Accessible DNA Sequence Database for Identifying Fusaria from Human and Animal Infections

    Authors: , , , , , , , , , , , , , , , , - Journal of Clinical Microbiology 2010 cited by 632

  3. Molecular Phylogenetic Diversity, Multilocus Haplotype Nomenclature, and In Vitro Antifungal Resistance within theFusarium solaniSpecies Complex

    Authors: , , , , , , , - Journal of Clinical Microbiology 2008 cited by 471

  4. Increase inCandida kruseiInfection among Patients with Bone Marrow Transplantation and Neutropenia Treated Prophylactically with Fluconazole

    Authors: , , , , , - New England Journal of Medicine 1991 cited by 947

  5. Candida krusei , a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005

    Authors: , , , , , , , , , - Journal of Clinical Microbiology 2007 cited by 255

  6. Novel Multilocus Sequence Typing Scheme Reveals High Genetic Diversity of Human Pathogenic Members of theFusarium incarnatum-F.equisetiandF. chlamydosporumSpecies Complexes within the United States

    Authors: , , , , , - Journal of Clinical Microbiology 2009 cited by 276

  7. Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin

    Authors: , , , , , , , , , - Journal of Clinical Microbiology 2007 cited by 175

  8. In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents

    Authors: , , , , - Antimicrobial Agents and Chemotherapy 2007 cited by 284

  9. Multicenter evaluation of four methods of yeast inoculum preparation

    Authors: , , , - Journal of Clinical Microbiology 1988 cited by 457

  10. Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

    Authors: , , , , , , , , - Journal of Clinical Microbiology 2010 cited by 236

  11. Risk factors for candidemia in Neonatal Intensive Care Unit patients

    Authors: , , , , , , , , , , , - The Pediatric Infectious Disease Journal 2000 cited by 590

  12. Genetic Diversity of Human Pathogenic Members of the Fusarium oxysporum Complex Inferred from Multilocus DNA Sequence Data and Amplified Fragment Length Polymorphism Analyses: Evidence for the Recent Dispersion of a Geographically Widespread Clonal Lineage and Nosocomial Origin

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Microbiology 2004 cited by 256

  13. Zygomycosis in Solid Organ Transplant Recipients in a Tertiary Transplant Center and Review of the Literature

    Authors: , , , , , - American Journal of Transplantation 2006 cited by 277

  14. Spectrum of Clinically Relevant Acremonium Species in the United States

    Authors: , , , , , , , , - Journal of Clinical Microbiology 2010 cited by 142

  15. Primary Central Nervous System Phaeohyphomycosis: A Review of 101 Cases

    Authors: , , - Clinical Infectious Diseases 2004 cited by 401

  16. In Vitro Antifungal Activity of Nikkomycin Z in Combination with Fluconazole or Itraconazole

    Authors: , - Antimicrobial Agents and Chemotherapy 1999 cited by 129

  17. Pseudomycins, a family of novel peptides from Pseudomonas syringae possessing broad-spectrum antifungal activity.

    Authors: , , , - Journal of General Microbiology 1991 cited by 122

  18. Taxonomy and phylogeny of theFusarium dimerumspecies group

    Authors: , , , , , , , , - Mycologia 2009 cited by 98

  19. Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes

    Authors: , , , , , , , , - Medicine 2000 cited by 790

  20. Risk Factors for Candidal Bloodstream Infections in Surgical Intensive Care Unit Patients: The NEMIS Prospective Multicenter Study

    Authors: , , , , , , , , , , , - Clinical Infectious Diseases 2001 cited by 660

  21. Experimental Pulmonary Aspergillosis Due toAspergillus terreus:Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B

    Authors: , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2003 cited by 255

  22. Results from the ARTEMIS DISK Global AntifungalSurveillance Study: a 6.5-Year Analysis of Susceptibilitiesof Candida and Other Yeast Species to Fluconazole andVoriconazole by Standardized Disk Diffusion Testing

    Authors: , , , , , , , , - Journal of Clinical Microbiology 2005 cited by 224

  23. Quality Control and Reference Guidelines for CLSI Broth Microdilution Susceptibility Method (M38-A Document) for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole

    Authors: , , , , , , , , - Journal of Clinical Microbiology 2005 cited by 99

  24. Disseminated Phaeohyphomycosis: Review of an Emerging Mycosis

    Authors: , , , , - Clinical Infectious Diseases 2002 cited by 396